CliniSys has won a major contract to deploy a single laboratory information system across Northern Ireland as part of a modernisation programme to create a world-class pathology service for the country.
CliniSys will replace the seven IT systems used by Northern Ireland’s hospital trusts' pathology disciplines and the Northern Ireland Blood Transfusion service with the latest version of WinPath Enterprise.
Healthcare professionals at Queen's Hospital Burton will be better placed to get patients home safely and as early as possible, whilst freeing up urgently needed capacity, with the help of a technology soon to be deployed.
Following the success of the ExtraMed Patient Flow solution at Royal Derby Hospital, where staff have reduced lengths of stay and enhanced care for patients,
Today, the U.S. Food and Drug Administration cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly a decade.
"Computed tomography is an important medical imaging tool that can aid in diagnosing disease, trauma or abnormality; planning and guiding interventional or therapeutic procedures; and monitoring the effectiveness of certain therapies," said Laurel Burk, Ph.D., assistant director of the Diagnostic X-ray Systems Team in the FDA's Center for Devices and Radiological Health.
Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals who examine body tissues (pathologists) in the detection of areas that are suspicious for cancer as an adjunct (supplement) to the review of digitally-scanned slide images from prostate biopsies (tissue removed from the body). Pathologists at one of England's most innovative trusts have chosen the CliniSys laboratory information system (LIMS) as part of a digital strategy to support its drive to continually improve patient care.
The pathology team at Northumbria Healthcare NHS Foundation Trust has decided to replace their legacy LIMS with WinPath Enterprise, hosted by CliniSys from its UK data centre.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche's uPath enterprise software, an application for pathologist workflow. This open environment allows for the secure exchange and flow of data so that pathologists can access advanced algorithms from third parties alongside Roche's menu of artificial intelligence-based image analysis tools.